There’s a reason why so many millionaires invest in real estate. It’s one of the most time-tested asset classes in existence: U.S. home values have appreciated at an average of 4%+ annually since 1967.* But with traditionally high investment minimums, the system was never designed for
Did you get James’ Emergency Alert? Click to Save Your Seat for Sunday Night’s Emergency Briefing When James told me what he believes Elon Musk is planning right now, in the wake of the SpaceX IPO… I couldn’t believe what he had to say. This has the potential
⚠️48-HOUR WARNING My Emergency Briefing Goes Live Sunday at 7 PM (ET) >>Click to Reserve Your Seat<< This is a 48-hour warning. This Sunday at 7PM (ET), I am hosting a Live Emergency Briefing to cover a massive announcement I believe is coming soon
I am ringing the alarm. I just found out that Elon Musk is scheduled to make an announcement early next week… And I believe he is going to say something that could result in a potential 700%-plus gain by the end of the month for investors who know how
Every year, $240B is spent on treating the symptoms of osteoarthritis, a disease that leads to joint degradation and eventually, immobility. With 500M people afflicted, its total addressable market is worth $560B. Despite decades of research, not a single therapy has been able to actually stop it. It turns out
The world spends $240 billion a year on osteoarthritis. Every. Single. Year. And none of it works. All that money buys you cortisone shots. painkillers and, eventually, a knee replacement. It manages the symptoms. But the cartilage keeps wearing away no matter what you do — and sooner or later, the
Modern medicine has spent decades — and hundreds of billions of dollars — trying to cure osteoarthritis. But they failed. Every drug on the market just masks the pain while cartilage continues to deteriorate. That's not a cure. It's a cover-up. Which is why Cytonics caught my
As a third-generation Brazilian Jiu-Jitsu master and former WWE champion, few people understand joint health like Rener and Eve Gracie. They’ve dedicated their lives to keeping the body in peak shape. So when they made a significant investment into Cytonics, the medical and investment world noticed. Cytonics
Every year, $240B is spent on treating the symptoms of osteoarthritis, a disease that leads to joint degradation and eventually, immobility. With 500M people afflicted, its total addressable market is worth $560B. Despite decades of research, not a single therapy has been able to actually stop it. It turns out
Get ahead with sharp, no-nonsense market insights that turn information into action
By 2030, AI data centers alone could consume as much electricity as entire nations like Sweden or Argentina. Today’s grid wasn’t built for this. That’s where Frontieras comes in. Their patented FASFormTM technology breaks coal down to produce clean fuels, hydrogen, fertilizer, and more. All from one
On July 4th, America turned 250 years old. For two and a half centuries, this country has done one thing better than anyone: solve problems. We industrialized a continent. We put men on the moon. We turned shale rock into the largest energy boom in history. Every one of those
America has the lithium in the ground and the patents to extract it. What's been missing is someone willing to build the plant. For decades, we outsourced the most critical supply chain in the modern economy. China processes our lithium. Chile and Argentina extract it. And everything ships
General Motors doesn't lead $50 million investments by accident. When one of the largest automakers on Earth leads a funding round into a private company, serious investors should ask a simple question: Why? The answer is straightforward. GM has staked its future on electric vehicles. Electric vehicles require
There's a land grab happening in Arkansas right now that reminds me of the early days of the shale boom. And most investors are completely missing it. Energy giants like Exxon and Chevron are spending billions buying up land in the Smackover Formation – one of the richest domestic
Everyone is chasing AI software stocks. And that's a mistake… The best investors I know are buying the physical power required to keep AI running. Here's what most investors don't understand… Tech giants are spending hundreds of billions building massive AI data centers. But
AI Needs Power. Power Needs Nuclear. Nuclear Needs This. The AI boom has created a power crisis. Data centers are devouring electricity, and the solution everyone’s converging on is nuclear, from fusion startups to next generation reactors. Here’s what most investors don’t know: advanced nuclear runs on
America’s Defense Tech Runs on Batteries Made in China. This Company Wants to End That. Most of the battery materials powering U.S. energy storage, EVs, drones, and defense platforms come from one place: China. In 2026, that’s no longer just an economic risk. It’s a strategic
Editor’s note: You can now predict stock moves with the same technology that allows SpaceX, NASA, and Blue Origin to predict the path of satellites in space with near-perfect accuracy. That’s according to Dr. David “Doc” Eifrig, CEO of MarketWise. See how this new breakthrough system delivered
Eni, a $40 billion global energy supermajor, just agreed to invest up to $225 million into a private U.S. lithium company's Chilean project called Black Giant™. Goldman Sachs advised the deal. Why? Lithium crisis: The IEA projects lithium demand will grow 5x by 2040. Supply is expected
Most people still don't understand what's happening with lithium. They see electric vehicles. They see battery storage. They know, vaguely, that "critical minerals" matter. But they don't understand the economics – the staggering gap between the lithium the world needs and the lithium
You can now predict stock moves with the same technology that allows SpaceX, NASA, and Blue Origin to predict the path of satellites in space with near-perfect accuracy. See how this system delivered 18,267 winning trades in back testing, including 1,009% on AST SpaceMobile... 1,663% on